Center for biologics evaluation and research (CBER) has a requirement for their biologics effectiveness and safety (BEST) initiative #3: health care data sources for surveillance of biologics (BEST 3)

Active Awarded Last action

Contract number
75F40124D00041
Awardee
Awarding agency
Task orders
0

Award facts

Last date to order 42% complete
IDV ceiling
$75,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 8 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) awarded a $75 million indefinite delivery contract to Acumen LLC (doing business as Medric) on September 27, 2024, to support the Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics. This multiple-award, unrestricted competition contract extends through September 29, 2029, and requires the contractor to provide large-scale, longitudinal healthcare data encompassing tens of millions of U.S. patients, including administrative claims data, claims combined with electronic health record data, and access to full medical charts for patient data review and adjudication. Acumen LLC, headquartered in Burlingame, California, serves as a data analytics and healthcare research services provider with established expertise in managing complex healthcare datasets for federal agencies.

The contract supports FDA's surveillance and monitoring objectives for biological products by leveraging Acumen LLC's core competencies in data modeling, analysis, and technical assistance. As a specialized provider of healthcare data infrastructure and analytics, the contractor will deliver epidemiological surveillance capabilities that enable CBER to assess the real-world effectiveness and safety profiles of biologics within the U.S. population. This indefinite delivery vehicle structure allows CBER to issue task orders over the five-year performance period to access and analyze healthcare data as needed for regulatory decision-making and post-market surveillance activities. Acumen LLC's existing contract portfolio with the Centers for Medicare and Medicaid Services, National Institutes of Health, and Centers for Disease Control and Prevention demonstrates relevant experience in federal healthcare data management and analysis initiatives.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $10,000

Quick answers

Who was awarded contract 75F40124D00041?

75F40124D00041 was awarded to Acumen LLC by Food and Drug Administration (Department of Health and Human Services) on September 27, 2024.

How much is contract 75F40124D00041 worth?

75F40124D00041's own ceiling is $75,000,000.

Who can order from contract 75F40124D00041?

75F40124D00041 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract 75F40124D00041 part of a contract vehicle?

Yes. 75F40124D00041 is part of CBER BEST Initiative 3 - Data Sources for Surveillance of Biologics.

Was contract 75F40124D00041 competed?

The extent of competition for 75F40124D00041 was full and open competition. The government received 8 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV